Suggesting Ritonavir against COVID-19/SARS-CoV-2

被引：0

作者：

Choudhury, Shuvasish ^{[1
]}

Mazumder, Muhammed Khairujjaman ^{[2
]}

机构：

[1] Assam Univ, Dept Life Sci & Bioinformat, Silchar 788011, Assam, India

[2] Dhemaji Coll, Dept Zool, Dhemaji 787057, Assam, India

来源：

MEDICAL HYPOTHESES | 2020年 / 140卷

关键词：

D O I：

10.1016/j.mehy.2020.109764

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页数：1

共 3 条

[1] Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings [J].

Chu, CM ;

Cheng, VCC ;

Hung, IFN ;

Wong, MML ;

Chan, KH ;

Chan, KS ;

Kao, RYT ;

Poon, LLM ;

Wong, CLP ;

Guan, Y ;

Peiris, JSM ;

Yuen, KY .

THORAX, 2004, 59 (03) :252-256

[2] Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods [J].

Wu, Canrong ;

Liu, Yang ;

Yang, Yueying ;

Zhang, Peng ;

Zhong, Wu ;

Wang, Yali ;

Wang, Qiqi ;

Xu, Yang ;

Li, Mingxue ;

Li, Xingzhou ;

Zheng, Mengzhu ;

Chen, Lixia ;

Li, Hua .

ACTA PHARMACEUTICA SINICA B, 2020, 10 (05) :766-788

[3] Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors [J].

Zhang, Linlin ;

Lin, Daizong ;

Sun, Xinyuanyuan ;

Curth, Ute ;

Drosten, Christian ;

Sauerhering, Lucie ;

Becker, Stephan ;

Rox, Katharina ;

Hilgenfeld, Rolf .

SCIENCE, 2020, 368 (6489) :409-+

← 1 →